FluoroPharma Medical, Inc. announce the appointment of Thijs Spoor, to the position of chairman of the board. Mr. Spoor will assume the role formerly held by Dr. David Elmaleh, who has left the company. Mr. Spoor will also continue as President and CEO. Mr. Spoor was appointed President and CEO of FluoroPharma Inc. on September 15, 2010. He was previously CFO for Sunstone BioSciences. Prior to joining Sunstone BioSciences, he worked as a consultant at Oliver Wyman, focusing on pharmaceutical and medical device companies.